Implantica AG

8IM1

Company Profile

  • Business description

    Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. Its lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results.

  • Contact

    Aeulestrasse 45
    Vaduz9490
    LIE

    T: +423 3766066

    https://www.implantica.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    Employees

    60

Stocks News & Analysis

stocks

Investors cheer Guzman dialing back global ambitions

Our view after US restaurants are closed.
stocks

Why stocks sometimes fall for no obvious reason

How the private markets impact all equity investors.
stocks

Poor organic growth obscured by acquisition for ASX listed share

Sales dropped by 2% without impact of acquisition.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,882.6020.50-0.23%
CAC 408,200.8457.42-0.70%
DAX 4025,276.29112.81-0.44%
Dow JONES (US)50,579.70294.040.58%
FTSE 10010,526.7860.520.58%
HKSE25,599.456.58-0.03%
NASDAQ26,343.9750.870.19%
Nikkei 22564,996.09162.10-0.25%
NZX 50 Index13,069.7499.460.77%
S&P 5007,473.470.000.00%
S&P/ASX 2008,657.8018.80-0.22%
SSE Composite Index4,145.377.20-0.17%

Market Movers